Regulation of Brain Functions by Adenosine A_2A Receptors: Implication for TherapeuticsPOPOLI, Patrizia.Current pharmaceutical design. 2008, Vol 14, Num 15, issn 1381-6128, 314 p.Serial Issue

New challenges in translational medicine: transforming the advancement of science into curesGARACI, Enrico; POPOLI, Patrizia.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, issn 0021-2571, 111 p.Serial Issue

A Critical Evaluation of Adenosine A_2A Receptors as Potentially Druggable Targets in Huntington's DiseasePOPOLI, Patrizia; BLUM, David; ROSARIA DOMENICI, Maria et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1500-1511, issn 1381-6128, 12 p.Article

The role of the Istituto Superiore di Sanità as the competent authority for Phase I trials in the translation of advanced therapiesPOPOLI, Patrizia; COMETA, Maria Francesca; FABI, Fulvia et al.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 79-82, issn 0021-2571, 4 p.Article

The personalised medicine. A paradigm of evidence-based medicineKUMAR, Dhavendra.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 31-40, issn 0021-2571, 10 p.Article

Need to improve clinical trials in rare neurodegenerative disordersPUOPOLO, Maria; POCCHIARI, Maurizio.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 55-59, issn 0021-2571, 5 p.Article

Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A_2A ReceptorsCHEN, Jiang-Fan; PEDATA, Felicita.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1490-1499, issn 1381-6128, 10 p.Article

SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slicesTEBANO, Maria Teresa; DOMENICI, Maria Rosaria; POPOLI, Patrizia et al.European journal of pharmacology. 2002, Vol 450, Num 3, pp 253-257, issn 0014-2999Article

Why rare diseases?REMUZZI, Giuseppe; SCHIEPPATI, Arrigo.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 94-97, issn 0021-2571, 4 p.Article

The discovery and development of HIV therapy: the new challengesFEDERICO PERNO, Carlo.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 41-43, issn 0021-2571, 3 p.Article

Clinical trials and gender medicineCASSESE, Mariarita; ZUBER, Veronica.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 100-103, issn 0021-2571, 4 p.Article

Drugs and clinical trials in neurodegenerative diseasesSTANZIONE, Paolo; TROPEPI, Domenicantonio.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 49-54, issn 0021-2571, 6 p.Article

Orphan drugs assessment in the centralised procedureNISTICO, Giuseppe.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 98-99, issn 0021-2571, 2 p.Article

Integrating clinical research into clinical decision makingTONELLI, Mark R.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 26-30, issn 0021-2571, 5 p.Article

A brief history of antiretroviral therapy of HIV infection: success and challengesPALMISANO, Lucia; VELLA, Stefano.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 44-48, issn 0021-2571, 5 p.Article

How to cope with complexity and adapt new scenarios to patient careDOMPE, Sergio.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 104-108, issn 0021-2571, 5 p.Article

Adenosine A_2A Receptor Antagonists and Parkinson's Disease : State of the Art and Future DirectionsSIMOLA, N; MORELLI, M; PINNA, A et al.Current pharmaceutical design. 2008, Vol 14, Num 15, pp 1475-1489, issn 1381-6128, 15 p.Article

The Clinical Trials Transformation Initiative (CTTI)GRIGNOLO, Alberto.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 14-18, issn 0021-2571, 5 p.Article

New perspective and new challenges in clinical trial regulation in ItalyTOMINO, Carlo.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 19-21, issn 0021-2571, 3 p.Article

The dawn of mesoscopic approach in drug developmentGIULIANI, Alessandro.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 60-63, issn 0021-2571, 4 p.Article

Innovative approaches to clinical development and trial designORLOFF, John J; STANSKI, Donald.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 8-13, issn 0021-2571, 6 p.Article

Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neuronsPEPPONI, Rita; FERRANTE, Antonella; FERRETTI, Roberta et al.European journal of pharmacology. 2009, Vol 617, Num 1-3, pp 28-32, issn 0014-2999, 5 p.Article

Evidence-based medicine: what it can and cannot doFREDDI, Goffredo; LUIS ROMAN-PUMAR, Jose.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 22-25, issn 0021-2571, 4 p.Article

The mGlu₅ receptor agonist CHPG stimulates striatal glutamate release : possible involvement of A_2A receptorsPINTOR, Annita; PEZZOLA, Antonella; REGGIO, Rosaria et al.Neuroreport (Oxford). 2000, Vol 11, Num 16, pp 3611-3614, issn 0959-4965Article

Translating basic research in cancer patient careMAUGERI-SACCA, Marcello; DE MARIA, Ruggero.Annali dell' Istituto superiore di sanità. 2011, Vol 47, Num 1, pp 64-71, issn 0021-2571, 8 p.Article